| Silver Springs Health Care Center | |
| 1300 West Silver Spring Dr, Glendale, Wisconsin 53209 | |
| (414) 228-8120 | |
| Name | Silver Springs Health Care Center |
|---|---|
| Location | 1300 West Silver Spring Dr, Glendale, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 112 |
| Occupancy Rate | 68.75% |
| Medicare ID (CCN) | 525371 |
| Legal Business Name | Bedrock Hcs At Glendale Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1205487345 |
| Organization Name | BEDROCK HCS AT GLENDALE LLC |
| Address | 1300 W Silver Spring Dr, Glendale, WI 53209 |
| Phone Number | 414-228-8120 |
News Archive
The University of Alabama at Birmingham recently integrated a clinical research management system that allows patient consent, data and documents from multiple sites to automatically flow from the the Enroll e-Consenting tablet application by Mytrus into the Velos eResearch interface.
It appears that the majority of spouses/partners of physicians in the United States are happy with their relationships, according to Mayo Clinic research.
A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.
A new study from MIT neuroscientists suggests that our ability to respond appropriately to intended harms - that is, with outrage toward the perpetrator - is seated in a brain region associated with regulating emotions.
BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), Washington University's Olin School of Business Skandalaris Student Venture Fund, and Integrated Magnetics, of Culver City, California. The funds will be used for further pre-clinical development.
› Verified 4 days ago
| NPI Number | 1790236966 |
| Organization Name | DYCORA TRANSITIONAL HEALTH - GLENDALE LLC |
| Address | 1300 W Silver Spring Dr, Glendale, WI 53209 |
| Phone Number | 414-228-8120 |
News Archive
The University of Alabama at Birmingham recently integrated a clinical research management system that allows patient consent, data and documents from multiple sites to automatically flow from the the Enroll e-Consenting tablet application by Mytrus into the Velos eResearch interface.
It appears that the majority of spouses/partners of physicians in the United States are happy with their relationships, according to Mayo Clinic research.
A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.
A new study from MIT neuroscientists suggests that our ability to respond appropriately to intended harms - that is, with outrage toward the perpetrator - is seated in a brain region associated with regulating emotions.
BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), Washington University's Olin School of Business Skandalaris Student Venture Fund, and Integrated Magnetics, of Culver City, California. The funds will be used for further pre-clinical development.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The University of Alabama at Birmingham recently integrated a clinical research management system that allows patient consent, data and documents from multiple sites to automatically flow from the the Enroll e-Consenting tablet application by Mytrus into the Velos eResearch interface.
It appears that the majority of spouses/partners of physicians in the United States are happy with their relationships, according to Mayo Clinic research.
A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.
A new study from MIT neuroscientists suggests that our ability to respond appropriately to intended harms - that is, with outrage toward the perpetrator - is seated in a brain region associated with regulating emotions.
BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), Washington University's Olin School of Business Skandalaris Student Venture Fund, and Integrated Magnetics, of Culver City, California. The funds will be used for further pre-clinical development.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $28168 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.82 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.07 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.63 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.43 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.78 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.74 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.5 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.27 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.03 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 78.79 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.17 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.29 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.86 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.21 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.77 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.77 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 67.66 | 82.93 |
News Archive
The University of Alabama at Birmingham recently integrated a clinical research management system that allows patient consent, data and documents from multiple sites to automatically flow from the the Enroll e-Consenting tablet application by Mytrus into the Velos eResearch interface.
It appears that the majority of spouses/partners of physicians in the United States are happy with their relationships, according to Mayo Clinic research.
A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.
A new study from MIT neuroscientists suggests that our ability to respond appropriately to intended harms - that is, with outrage toward the perpetrator - is seated in a brain region associated with regulating emotions.
BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), Washington University's Olin School of Business Skandalaris Student Venture Fund, and Integrated Magnetics, of Culver City, California. The funds will be used for further pre-clinical development.
› Verified 4 days ago
Silver Springs Health Care Center Location: 1300 West Silver Spring Dr, Glendale, Wisconsin 53209 Phone: (414) 228-8120 | |
Glendale Care And Rehab Center Llc Location: 6263 N Green Bay Ave, Glendale, Wisconsin 53209 Phone: (414) 351-0543 |